Luca Dezzani | The Pharmaceutical Marketing Group

Evaluation of Clinical Trial Costs and Barriers to Drug Development By Luca Dezzani

Luca Dezzani - September 20, 2018

Top 10 Pharmaceutical Companies 2018 – Cardiovascular by Luca Dezzani

Luca Dezzani - July 30, 2018

10 Best Selling Drugs 2018 – Oncology

Luca Dezzani - May 28, 2018

20 Best Selling Drugs 2018 by Luca Dezzani

Luca Dezzani - April 9, 2018

Best Pharmaceutical Companies – Quarterly Analysis – Q4 2017

Luca Dezzani - March 26, 2018

The Complete Guide to Pharmaceutical Salaries 2018

March 19, 2018

Top 10 Pharmaceutical Companies 2018

March 7, 2018

Top 31 Most Promising Drugs 2018

February 15, 2018

Best Selling Drugs 1997 – 2017

February 13, 2018

Best Consulting Firms for Healthcare 2018 by Luca Dezzani

February 5, 2018

Top 10 Pharmaceutical Companies 1997-2017

January 16, 2018

20 Years of Changes in Survival for Cancer

January 12, 2018

Top 10 Pharma Companies for R&D 1997 – 2017

January 9, 2018

Top 10 Pharmaceutical Companies 1997-2017

January 2, 2018

CRISPR Therapy 2017

December 15, 2017

Top 10 Oncology Drugs 1997 – 2017

December 6, 2017

Top 20 Diabetes Drugs 2017

November 13, 2017

Top 10 Pharmaceutical Companies 2017: Anti-Virals

November 7, 2017

PARP Inhibitors 2017

October 31, 2017

Good Forecasting: Fortune Telling or Systematic Predictions

October 30, 2017

Top 25 Rheumatology Drugs 2017

October 27, 2017

Top 5 Pharmaceutical Companies 2017: Vaccines

October 18, 2017

Cost of Cancer Drugs: R&D Spending vs Revenues

October 11, 2017

Top 10 Pharmaceutical Companies 2017: Anti-Virals

October 2, 2017

Top 10 Pharmaceutical Companies 2017: Anti-Diabetics

September 28, 2017

12 Page 1 of 2